A recent study [22] analyzing blood-derived ctDNA and tissue TP53 mutations in patients with various cancers found that TP53 was fully concordant in 45% (116/258) of cases with the mutations, a similar positive concordance rate was observed in our study (41.7%). The gene discussed is TP53; the disease is cancer.